252 related articles for article (PubMed ID: 19162337)
1. Interleukin-17 as a drug target in human disease.
Ivanov S; Lindén A
Trends Pharmacol Sci; 2009 Feb; 30(2):95-103. PubMed ID: 19162337
[TBL] [Abstract][Full Text] [Related]
2. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
[TBL] [Abstract][Full Text] [Related]
3. The roles of IL-17A in inflammatory immune responses and host defense against pathogens.
Iwakura Y; Nakae S; Saijo S; Ishigame H
Immunol Rev; 2008 Dec; 226():57-79. PubMed ID: 19161416
[TBL] [Abstract][Full Text] [Related]
4. IL-17-producing T cells in lung immunity and inflammation.
Nembrini C; Marsland BJ; Kopf M
J Allergy Clin Immunol; 2009 May; 123(5):986-94; quiz 995-6. PubMed ID: 19410688
[TBL] [Abstract][Full Text] [Related]
5. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation.
Kikly K; Liu L; Na S; Sedgwick JD
Curr Opin Immunol; 2006 Dec; 18(6):670-5. PubMed ID: 17010592
[TBL] [Abstract][Full Text] [Related]
6. The IL-17 pathway as a major therapeutic target in autoimmune diseases.
Hu Y; Shen F; Crellin NK; Ouyang W
Ann N Y Acad Sci; 2011 Jan; 1217():60-76. PubMed ID: 21155836
[TBL] [Abstract][Full Text] [Related]
7. The IL-17 cytokine family.
Gaffen SL; Kramer JM; Yu JJ; Shen F
Vitam Horm; 2006; 74():255-82. PubMed ID: 17027518
[TBL] [Abstract][Full Text] [Related]
8. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
Williams RO; Paleolog E; Feldmann M
Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
[TBL] [Abstract][Full Text] [Related]
9. Diseases that may benefit from manipulating the Th17 pathway.
Miossec P
Eur J Immunol; 2009 Mar; 39(3):667-9. PubMed ID: 19283719
[TBL] [Abstract][Full Text] [Related]
10. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.
Zhu S; Qian Y
Clin Sci (Lond); 2012 Jun; 122(11):487-511. PubMed ID: 22324470
[TBL] [Abstract][Full Text] [Related]
11. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice.
Jang E; Cho SH; Park H; Paik DJ; Kim JM; Youn J
J Immunol; 2009 Apr; 182(8):4649-56. PubMed ID: 19342640
[TBL] [Abstract][Full Text] [Related]
12. TLR3 ligand polyinosinic:polycytidylic acid induces IL-17A and IL-21 synthesis in human Th cells.
Holm CK; Petersen CC; Hvid M; Petersen L; Paludan SR; Deleuran B; Hokland M
J Immunol; 2009 Oct; 183(7):4422-31. PubMed ID: 19748983
[TBL] [Abstract][Full Text] [Related]
13. Functional specialization of interleukin-17 family members.
Iwakura Y; Ishigame H; Saijo S; Nakae S
Immunity; 2011 Feb; 34(2):149-62. PubMed ID: 21349428
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological modulation of Th17.
De Sanctis JB; Garmendia JV; Moreno D; Larocca N; Mijares M; Di Giulio C; Salazar-Bookaman M; Wojewodka G; Radzioch D
Recent Pat Inflamm Allergy Drug Discov; 2009 Jun; 3(2):149-56. PubMed ID: 19519592
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-12 family members and type I interferons in Th17-mediated inflammatory disorders.
Goriely S; Cavoy R; Goldman M
Allergy; 2009 May; 64(5):702-9. PubMed ID: 19383026
[TBL] [Abstract][Full Text] [Related]
16. Role of interleukin-17F in chronic inflammatory and allergic lung disease.
Hizawa N; Kawaguchi M; Huang SK; Nishimura M
Clin Exp Allergy; 2006 Sep; 36(9):1109-14. PubMed ID: 16961709
[TBL] [Abstract][Full Text] [Related]
17. IL-17 cytokine family.
Kawaguchi M; Adachi M; Oda N; Kokubu F; Huang SK
J Allergy Clin Immunol; 2004 Dec; 114(6):1265-73; quiz 1274. PubMed ID: 15577820
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 as a therapeutic target in candidate inflammatory diseases.
Nishimoto N
Clin Pharmacol Ther; 2010 Apr; 87(4):483-7. PubMed ID: 20182422
[TBL] [Abstract][Full Text] [Related]
19. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
[TBL] [Abstract][Full Text] [Related]
20. IL-17 and IL-22: siblings, not twins.
Eyerich S; Eyerich K; Cavani A; Schmidt-Weber C
Trends Immunol; 2010 Sep; 31(9):354-61. PubMed ID: 20691634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
